Romankiewicz J A, Ehrman M
Ann Intern Med. 1975 Feb;82(2):224-5. doi: 10.7326/0003-4819-82-2-224.
The drug interaction between warfarin and rifampin is not well known. Rifampin has been reported to increase the warfarin requirements in human subjects ingesting these agents simultaneously. The concomitant administration of rifampin and warfarin resulted in the need for an unusually high maintenance dose of warfarin (20 mg per day) in order to produce a therapeutic effect. Withdrawal of rifampin decreased the warfarin requirement by 50%. This effect may be mediated by the ability of rifampin to induce microsomal enzymes and, thus, the catabolism of warfarin. The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. This interaction appears to be clinically significant.
华法林与利福平之间的药物相互作用尚不为人熟知。据报道,在同时服用这两种药物的人体受试者中,利福平会增加华法林的需求量。利福平与华法林同时给药时,为了产生治疗效果,需要使用异常高的华法林维持剂量(每天20毫克)。停用利福平后,华法林的需求量降低了50%。这种效应可能是由利福平诱导微粒体酶从而使华法林分解代谢的能力介导的。利福平对我们这位患者华法林需求量的影响似乎在开始使用利福平后5至7天达到最大,并在停用利福平后持续相似的时长。这种相互作用在临床上似乎具有重要意义。